Nature Reviews Drug Discovery 14, 597–598 (2015)
The description of the nature of breakthrough designation has been revised, and details of an additional product that received breakthrough designation within the timeframe of the analysis have been added.
Additional information
The online version of the original article can be found at 10.1038/nrd4717
Rights and permissions
About this article
Cite this article
Chizkov, R., Million, R. Erratum: Trends in breakthrough therapy designation. Nat Rev Drug Discov 15, 216 (2016). https://doi.org/10.1038/nrd.2016.43
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.43
